Article

marketwatch.com on 2020-07-20 14:20

J.P. Morgan downgrades Moderna over valuation concerns

Analysts at J.P. Morgan downgraded shares of Moderna Inc. undefined to neutral from overweight over concerns about the valuation of the preclinical ...

Related news